Tirzepatide is a once-weekly injectable that activates two gut hormone receptors, GIP and GLP-1, rather than the single GLP-1 receptor targeted by semaglutide. It is the active ingredient in the brand-name medications Mounjaro and Zepbound. There is currently no generic tirzepatide approved in the United States.
Patients in our tirzepatide program receive a full medical evaluation, individualized dose titration, and ongoing monitoring. Whether tirzepatide is appropriate for you is a clinical decision your physician makes based on your history, current medications, and treatment goals.
Why Tirzepatide?
In the manufacturer's pivotal trials, tirzepatide produced greater average weight reduction than previously studied single-agonist therapies. Individual results vary substantially, and trial averages are not a prediction of any one patient's outcome.
Tirzepatide works best alongside nutrition and lifestyle support rather than on its own. Our program pairs the medication with coaching so the changes hold once dosing stabilizes.
Safety and Monitoring
Tirzepatide carries a boxed warning for thyroid C-cell tumors based on rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2. Gastrointestinal side effects such as nausea are the most commonly reported, and are usually managed with slower titration.
Your physician will review your full medication list, discuss contraindications, and set a follow-up schedule before you begin.
Related Patient Videos
Frequently Asked Questions
Is tirzepatide the same as Mounjaro or Zepbound?+
Tirzepatide is the active ingredient in both. Mounjaro is approved for type 2 diabetes and Zepbound for chronic weight management. There is no FDA-approved generic tirzepatide.
How is tirzepatide different from semaglutide?+
Semaglutide activates the GLP-1 receptor. Tirzepatide activates both GIP and GLP-1 receptors. Which is more appropriate depends on your medical history, tolerance, and goals — that is a conversation to have at your consultation.
Costs and appointment planning
Review pricing questions, insurance and coverage information, and telehealth visit planning before booking. Confirm the costs and services that apply to your individual care.
Ready to Get Started?
Call us at (404) 264-9553 or book a telehealth consultation. New patients qualify for our 1st month Semaglutide special — $399 (regularly $450).